HIV Testing WHO Unveils Positive New Guidelines for Lenacapavir and Updated Recommendations 2025
HIV Testing WHO Launches Guideline Development Group to Establish New HIV Prevention and Testing Standards for Lenacapavir The World Health Organization (WHO) has announced the formation of a new Guideline…
Biopharma Leaders Head to JPMorgan in Search of a Game-Changing M&A Boost to Revive Market Sentiment 2025
Biopharma Leaders M&A Didn’t Deliver as Expected in 2024: Biopharma Turns to JPMorgan Healthcare Conference for Optimism Biopharma Leaders the much-anticipated mergers and acquisitions (M&A) wave that the biopharma industry…
Gastric Cancer NMPA Approves VYLOYTM for Breakthrough Advanced Gastric Cancer Treatment 2025
Astellas Pharma recently announced the approval Gastric Cancer of VYLOYTM (zolbetuximab) by China’s National Medical Products Administration (NMPA) for first-line treatment of locally advanced unresectable or metastatic human epidermal growth…
Revolution Medicines Triumphantly Closes $862.5M Upsized Offering and Underwriters Option
Revolution Medicines, a clinical-stage oncology company focused on developing targeted therapies for patients with RAS-addicted cancers, recently announced the successful closing of its upsized underwritten public offering. The offering comprised…
Heart Disease Pearland Event Highlights Risks and Offers Valuable Free Heart and Kidney Health Screenings
Heart Disease: The Importance of Regular Health Screenings Care Access, a leading health Heart Disease and research company, is bringing its Heart & Kidney Health Screening initiative to Pearland, Texas.…
Cytokinetics Unveils Strategic 89,262 Inducement Grants in Compliance with Nasdaq Rule 5635(C)(4)
Cytokinetics, Incorporated has announced the granting of equity awards as material inducements to new employees under Nasdaq Listing Rule 5635(c)(4). These grants, made on December 31, 2024, include stock options,…
PharmaEssentia Commits to Reliable Access to Interferon Therapies Amid Supply Challenges 100%
Amid the growing global shortage of Pegasys® (peginterferon alfa-2a), PharmaEssentia (TWSE: 6446), a global biopharmaceutical company, is reaffirming its steadfast commitment to ensuring robust and reliable access to critical interferon…
Drug Approvals & Cancer Incidence Drive $400+ Bn Oncology Market by 2029
The oncology pharmaceuticals market, valued at $196.4 billion in 2023, is expected to grow at a robust compound annual growth rate (CAGR) of 12.7%, reaching $401.4 billion by 2029. This…
Propranolol Dramatically Alleviates Tremors in Parkinson’s Disease
Propranolol Reduces Tremors in Parkinson’s Disease: Insights into the Role of Stress and the Brain Parkinson’s disease is a progressive neurodegenerative disorder that affects movement, often leading to symptoms such…
Biologics Leader WuXi Tops 2024 Dow Jones Sustainability Indices for the Second Year in a Row
WuXi AppTec Recognized for Its Continued Commitment to Environmental, Social, and Governance Excellence WuXi Biologics a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has proudly announced its inclusion…
Genomics Growth in Precision Medicine Software Market 2024 4 Key Players Syapse, Fabric Genomics
The “Precision Medicine Software Market: Focused Insights 2024-2029” explores the dynamics Genomics of a rapidly growing industry. Valued at USD 1.72 billion in 2023, the market is expected to grow…
OS Therapies Successfully Completes $6 Million Private Placement
OS Therapies Announces $6 Million Private Placement to Fund Clinical Development of OST-HER2 for Osteosarcoma and Other Cancer Indications OS Therapies, a clinical-stage biotechnology company focused on developing innovative cancer…